,,iii #aacth ,,congress #b;d ,session ,s4 ,,res4 #cfh ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,february #bg1 #bjad ,mr4 ,brown 7for himself1 ,mr4 ,barrasso1 ,mr4 ,wicker1 ,mr4 ,coons1 ,mr4 ,bennet1 ,mr4 ,whitehouse1 ,mrs4 ,feinstein1 ,mr4 ,pryor1 and ,ms4 ,warren7 submitted the following resolution2 which was considered and agreed to ,,resolution ,designating ,february #bh1 #bjad1 as ,rare ,disease ,day4 ,whereas a rare disease or disorder is one that affects a small number of patients - in the ,united ,states1 typically less than #bjj1jjj individuals annually2 ,whereas as of the date of approval of this resolution1 nearly #g1jjj rare diseases affect approximately #cj1jjj1jjj people in the ,united ,states and their families2 ,whereas children with rare genetic diseases account for more than half of the population affected by rare diseases in the ,united ,states2 ,whereas many rare diseases are serious1 life-threatening1 and lack an effective treatment2 ,whereas great strides have been made in research and treatment for rare diseases as a result of the ,orphan ,drug ,act 7,public ,law #ig-dad72 ,whereas the ,food and ,drug ,administration has made great strides in involving the patient in the drug review process as part of its ,patient-,focused ,drug ,development program1 an initiative that originated in the ,food and ,drug ,administration ,safety and ,innovation ,act 7,public ,law #aab-add72 ,whereas a third of all treatments approved by the ,food and ,drug ,administration in #bjac were orphan products intended to treat rare diseases2 ,whereas lack of access to effective treatments and difficulty in obtaining reimbursement for life-altering1 and even life-saving1 treatments still exist and remain significant challenges for the rare disease community and their families2 ,whereas rare diseases and conditions include epidermolysis bullosa1 progeria1 sickle cell anemia1 spinal muscular atrophy 7,,sma71 ,duchenne muscular dystrophy 7,,dmd71 ,tay-,sachs1 cystic fibrosis1 pulmonary fibrosis1 many childhood cancers1 and fibrodysplasia ossificans progressiva2 ,whereas people with rare diseases experience challenges that include difficulty in obtaining accurate diagnoses1 limited treatment options1 and difficulty finding physicians or treatment centers with expertise in their diseases2 ,whereas the rare disease community made great strides in #bjac1 including the passage of the ,national ,pediatric ,research ,network ,act 7,public ,law #aac-ee71 which calls special attention to rare diseases and directs the ,national ,institutes of ,health to facilitate greater collaboration among researchers2 ,whereas both the ,food and ,drug ,administration and the ,national ,institutes of ,health have established special offices to advocate for rare disease research and treatments2 ,whereas the ,national ,organization for ,rare ,disorders1 an organization established in #aihc to provide services to and advocate on behalf of patients with rare diseases1 remains a critical public voice for people with rare diseases2 ,whereas #bjac marked the #cjth anniversary of the ,orphan ,drug ,act and the ,national ,organization for ,rare ,disorders2 ,whereas the ,national ,organization for ,rare ,disorders sponsors ,rare ,disease ,day in the ,united ,states to increase public awareness of rare diseases2 ,whereas ,rare ,disease ,day is observed each year on the last day of ,february2 ,whereas ,rare ,disease ,day is a global event1 first observed in the ,united ,states on ,february #bh1 #bjji1 and observed in #fj countries in #bjac2 and ,whereas ,rare ,disease ,day is expected to be observed globally for years to come1 providing hope and information for rare disease patients around the world3 ,now1 therefore1 be it ,that the ,senate-- 7#a7 designates ,february #bh1 #bjad1 as ,rare ,disease ,day2 7#b7 recognizes the importance of improving awareness and encouraging accurate and early diagnosis of rare diseases and disorders2 and 7#c7 supports a national and global commitment to improving access to1 and developing new treatments1 diagnostics1 and cures for rare diseases and disorders4